A randomized controlled trial of the efficacy and safety of saxagliptin as add‐on therapy in patients with type 2 diabetes and inadequate glycaemic control on …
… gov identifier) conducted at 35 outpatient centres in Australia, Canada, India, Korea, Thailand and the UK. The study comprised a screening and enrolment period (visits 1 and 2), during …..... Read More